A 2013 European survey of clinical practice patterns in the management of Graves' disease

Clinical Endocrinology

Volumn 84, Issue 1, 2016, Pages 115-120

  Bartalena, L ^a   Burch, H B ^b   Burman, K D ^c   Kahaly, G J ^d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; AUTOANTIBODY; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

BLOOD; CLINICAL PRACTICE; EUROPE; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOLOGY; NORTH AMERICA; PREGNANCY; PREGNANCY COMPLICATIONS; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ANTITHYROID AGENTS; AUTOANTIBODIES; EUROPE; FEMALE; GRAVES DISEASE; HUMANS; METHIMAZOLE; NORTH AMERICA; PRACTICE PATTERNS, PHYSICIANS'; PREGNANCY; PREGNANCY COMPLICATIONS; PROPYLTHIOURACIL; RECEPTORS, THYROTROPIN; SURVEYS AND QUESTIONNAIRES; THYROTROPIN; THYROXINE;

EID: 84956610505     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12688     Document Type: Review

References (34)

1. Brent, G.A., (2008) Clinical practice-Graves' disease. New England Journal of Medicine, 358, 2594-2605.
2. Prabhakar, B.S., Bahn, R.S., &, Smith, T.J., (2003) Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocrine Reviews, 24, 802-835.
3. Bartalena, L., (2013) Diagnosis and management of Graves disease: a global overview. Nature Reviews Endocrinology, 9, 724-734.
4. Burch, H.B., Burman, K.D., &, Cooper, D.S., (2012) A survey of clinical practice patterns in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 97, 4549-4558.
5. Glinoer, D., Hesch, D., Lagasse, R., et al,. (1987) The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. Acta Endocrinologica (Copenhagen), 285 (Suppl), 3-23.
6. Solomon, B., Glinoer, D., Lagasse, R., et al,. (1990) Current trends in the management of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 70, 1518-1524.
7. Wartofsky, L., Glinoer, D., Solomon, B., et al,. (1991) Differences and similarities in the diagnosis and treatment of diffuse goiter in Europe, Japan and the United States. Thyroid, 1, 129-135.
8. Bahn, R.S., Burch, H.B., Cooper, D.S., et al,. (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21, 593-646.
9. Diana, T., Brown, R.S., Bossowski, A., et al,. (2014) Clinical relevance of thyroid-stimulating autoantibodies in pediatric Graves' disease-a multicentre study. Journal of Clinical Endocrinology and Metabolism, 99, 1648-1655.
10. Leschik, J.J., Diana, T., Olivo, P.D., et al,. (2013) Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins. American Journal of Clinical Pathology, 139, 192-200.
11. Lytton, S.D., &, Kahaly, G.J., (2010) Bioassays for TSH-receptor autoantibodies: an update. Autoimmunity Reviews, 10, 116-122.
12. Ajjan, R.A., &, Weetman, A.P., (2008) Techniques to quantify TSH receptor antibodies. Nature Clinical Practice Endocrinology & Metabolism, 4, 461-468.
13. Tozzoli, R., Bagnasco, M., Giavarina, D., et al,. (2013) TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmunity Reviews, 12, 107-113.
14. Schott, M., Hermsen, D., Broecker-Preuss, M., et al,. (2009) Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial. Clinical Endocrinology (Oxford), 71, 566-573.
15. Lytton, S.D., Li, Y., Olivo, P.D., et al,. (2010) Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins. Clinical and Experimental Immunology 162, 438-446.
16. Kamijo, K., Murayama, H., Uzu, T., et al,. (2010) A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells. Thyroid, 20, 851-856.
17. Kahaly, G.J., Bartalena, L., &, Hegedus, L., (2011) The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective. Thyroid, 21, 585-591.
18. Yamashita, S., Amino, N., &, Shong, Y.S., (2011) The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines: viewpoints from Japan and Korea. Thyroid, 21, 577-580.
19. Barbesino, G., &, Tomer, Y., (2013) Clinical utility of TSH receptor antibodies. Journal of Clinical Endocrinology and Metabolism, 98, 2247-2255.
20. Cappelli, C., Pirola, I., De Martino, E., et al,. (2008) The role of imaging in Graves' disease: a cost-effectiveness analysis. European Journal of Radiology, 65, 99-103.
21. Emiliano, A.B., Governale, L., Parks, M., et al,. (2010) Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. Journal of Clinical Endocrinology & Metabolism, 95, 2227-2233.
22. Stagnaro-Green, A., Abalovich, M., Alexander, E., et al,. (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 2, 1081-1125.
23. DeGroot, L.J., Abalovich, M., Alexander, E.K., et al,. (2012) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 97, 2543-2565.
24. Bartalena, L., &, Fatourechi, V., (2014) Extrathyroidal manifestations of Graves' disease: a 2014 update. Journal of Endocrinological Investigation, 37, 691-700.
25. Tanda, M.L., Piantanida, E., Liparulo, L., et al,. (2013) Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center. Journal of Clinical Endocrinology and Metabolism, 98, 1443-1449.
26. Piantanida, E., Tanda, M.L., Lai, A., et al,. (2013) Prevalence and natural history of Graves' orbitopathy in the XXI century. Journal of Endocrinological Investigation, 36, 444-449.
27. Bartalena, L., (2011) The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. Journal of Clinical Endocrinology and Metabolism, 96, 592-599.
28. Elbers, L., Mourits, M., &, Wiersinga, W.M., (2011) Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy. Thyroid, 21, 279-283.
29. Laurberg, P., Berman, D.C., Andersen, S., et al,. (2011) Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. Thyroid, 21, 951-956.
30. Menconi, F., Marinò, M., Pinchera, A., et al,. (2007) Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. Journal of Clinical Endocrinology and Metabolism, 92, 1653-1658.
31. Moleti, M., Violi, M.A., Montanini, D., et al,. (2014) Radioiodine ablation of postsurgical thyroid remnants with recombinant human TSH (rhTSH) in patients with moderate-to-severe Graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial. Journal of Clinical Endocrinology and Metabolism, 99, 1783-1789.
32. Bartalena, L., Baldeschi, L., Dickinson, A., et al,. (2008) Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of GO. European Journal of Endocrinology, 158, 273-285.
33. Lai, A., Sassi, L., Compri, E., et al,. (2010) Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study. Journal of Clinical Endocrinology and Metabolism, 95, 1333-1337.
34. Shiber, S., Stiebel-Kalish, H., Shimon, I., et al,. (2014) Glucocorticoid regimens for prevention of Graves' ophthalmopathy progression following radioiodine treatment: systematic review and meta-analysis. Thyroid, 24, 1515-1523.